Alan M. Levine - 09 Jun 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: Director
Signature: /s/ Marc Began, as attorney-in-fact for Alan Levine
Issuer symbol: AXGN
Transactions as of: 09 Jun 2025
Net transactions value: -$43,215
Form type: 4
Filing time: 11 Jun 2025, 16:26:56 UTC
Previous filing: 04 Sep 2024
Next filing: 20 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Levine Alan M	Director	C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400, ALACHUA	/s/ Marc Began, as attorney-in-fact for Alan Levine	11 Jun 2025	0001766833

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Sale	$43,215	-4,073	-10%	$10.61	36,743	09 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average sale price. These shares were sold on June 9, 2025 in multiple transactions at prices ranging from $10.47 to $10.61 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Content

The reported price in Column 4 is a weighted average sale price. These shares were sold on June 9, 2025 in multiple transactions at prices ranging from $10.47 to $10.61 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.